Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Effects of albiglutide on myocardial infarction and ischaemic heart disease outcomes in patients with type 2 diabetes and cardiovascular disease in the Harmony Outcomes trial

European Heart Journal - Cardiovascular Pharmacotherapy(2024)10.1093/ehjcvp/pvae006Source: DataRank Database

Effects of albiglutide on myocardial infarction and ischaemic heart disease outcomes in patients with type 2 diabetes and cardiovascular disease in the Harmony Outcomes trial is a research paper published in European Heart Journal - Cardiovascular Pharmacotherapy (2024). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: greenTopics (41)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Guillaume Marquis‐Gravel ORCID,Shannon Murphy ORCID,Karen P. Alexander ORCID,Karen Chiswell ORCID,Jennifer B. Green ORCID

Live enrichment

PubMed:38271596

NHLBI NIH HHS

Grant: UG3 HL146935

NHLBI NIH HHS

Grant: UH3 HL146935

Duke Clinical Research Institute

Max Kade Foundation

greenLicense: https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC13031111/

publisherhttps://academic.oup.com/ehjcvp/advance-article-pdf/doi/10.1093/ehjcvp/pvae006/56747467/pvae006.pdf

publisherhttps://academic.oup.com/ehjcvp/article-pdf/10/4/279/58555393/pvae006.pdf

Fields of Study

HumansDiabetes Mellitus, Type 2MaleFemaleDouble-Blind MethodMiddle AgedTreatment OutcomeAgedMyocardial InfarctionGlucagon-Like Peptide 1Hypoglycemic AgentsTime FactorsIncretinsRisk AssessmentMyocardial IschemiaRisk FactorsGlucagon-Like Peptide-1 Receptor AgonistsGlucagon-Like Peptide-1 Receptor

MeSH Terms

Keywords

AlbiglutideDiabetesGLP1-receptor agonistsMyocardial infarctionOutcomes